For citations:
Lomaia E.G., Siordia N.T., Kulemina O.V., Strugov V.V., Senderova O.M., Ochirova O.Е., Zhalsanova E.B., Furtovskaya A.Yu., Alekseeva Yu.A., Lazorko N.S., Sbityakova E.I., Dimov G.P., Pozina M.G., Li O.Yu., Trizna K.B., Mikhalev M.A., Sokurova E.V., Otmorskaya A.A., Khazieva A.S., Ustyantseva V.V., Matvienko Yu.D., Zaritsky A.Yu. Еarly splenic response to ruxolitinib correlates with survival: a russian retrospective multicenter study in patients with myelofibrosis. Russian Journal for Personalized Medicine. 2023;3(3):64-78. (In Russ.) https://doi.org/10.18705/2782-3806-2023-3-3-64-78
Email this article 